MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$4,010,773
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Research and development
2,131,444
3,724,755
General and administrative
1,898,397
2,348,227
Total operating expenses
4,029,841
6,072,982
Loss from operations
-4,029,841
-6,072,982
(loss) gain on remeasurement of warrant liabilities
-27,816
11,126
Interest expense
2,605
4,797
Interest income
59,103
22,847
Other expense, net
-6,774
-1,850
Total other income, net
21,908
27,326
Loss before provision for income taxes
-4,007,933
-6,045,656
Provision for income taxes
2,840
7,954
Net loss
-4,010,773
-6,053,610
Basic EPS
-0.06
-0.12
Basic Average Shares
72,685,740
49,847,872
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$4,010,773
Interest income
$59,103
Loss before
provision for income taxes
-$4,007,933
Provision for income taxes
$2,840
Total other income,
net
$21,908
(loss) gain on
remeasurement of warrant...
-$27,816
Other expense, net
-$6,774
Interest expense
$2,605
Loss from operations
-$4,029,841
Total operating
expenses
$4,029,841
Research and development
$2,131,444
General and
administrative
$1,898,397
Buy us a coffee
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)